Comments

Verona Pharma Stock Price, Quotes and Forecasts

Q: What sector and industry does Verona Pharma (VRNA) operate in?

Verona Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

VRNANASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$90.92

-2.01-2.16%

At close: -

$91.89

0.971.07%

After Hours: 5:27 PM EDT

Verona Pharma (VRNA) Forecast

News Earnings Verona Pharma (VRNA) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Verona Pharma Stock Price, Quotes and Forecasts | NASDAQ:VRNA | Benzinga

Explore Verona Pharma stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for VRNA.

Open	$93.86
Close	$90.92
Volume / Avg.	1.01M / 1.39M
Day Range	$89.69 - $94.20
52 Wk Range	14.14 - 94.45
Market Cap	$7.81B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	75
Short Interest	8.75%
Days to Cover	5.43

Recent News

Oracle To Rally More Than 20%? Here Are 10 Top Analyst Forecasts For Wednesday

Avi Kapoor

Regeneron, Sanofi Stock Falls After Uneven Smoker's Lung Drug Data

Regeneron and Sanofi's COPD drug itepekimab cut exacerbations by 27% in one Phase 3 trial, while the second trial did not meet its main goal.

Vandana Singh

Jim Cramer Says This Quantum Computing Stock Is 'So High' And 'Too Speculative'

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jan

Feb

Apr

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$93.86
Close	$90.92
Volume / Avg.	1.01M / 1.39M
Day Range	$89.69 - $94.20
52 Wk Range	14.14 - 94.45
Market Cap	$7.81B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	75
Short Interest	8.75%
Days to Cover	5.43

About Verona Pharma PLC

Sector

Health Care

Industry

Pharmaceuticals

Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercial...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Verona Pharma (VRNA) stock?

You can purchase shares of Verona Pharma (NASDAQ:VRNA) through any online brokerage.

View our list of the best stock brokerages

Who are Verona Pharma (VRNA) competitors?

Other companies in Verona Pharma’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Haleon (NYSE:HLN).

What is the forecast, or price target, for Verona Pharma (VRNA) stock?

Verona Pharma has a consensus price target of $74.55.

What is the current price for Verona Pharma (VRNA)?

The stock price for Verona Pharma (NASDAQ: VRNA) is $91.89 last updated June 18, 2025 at 5:27 PM EDT.

Does Verona Pharma (VRNA) pay a dividend?

There are no upcoming dividends for Verona Pharma.

When is Verona Pharma (NASDAQ:VRNA) reporting earnings?

Verona Pharma’s Q2 earnings are confirmed for Thursday, August 7, 2025.

Is Verona Pharma (VRNA) going to split?

There is no upcoming split for Verona Pharma.

What sector and industry does Verona Pharma (VRNA) operate in?

Verona Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.